Pharvaris N.V. (PHVS)
Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.
Address
J.H. OORTWEG 21
LEIDEN, P7 00000
Founded
2015
Number of Employees
82
Website
http://www.pharvaris.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)